菲立磁增強MRI對局灶性肝病的定性診斷價值_《中國普外基礎與臨床雜志》

作者：

楊漢豐 , 宋彬 , 周翔平 , 余建群 , 陳衛霞 , 陳憲 , 孫家瑜 , 陳茀茀 , 朱紅梅

四川大學華西醫院放射科（成都610041）;

關鍵詞：

局灶性肝病磁共振成像 ROC曲線診斷

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的對比分析菲立磁增強掃描與螺旋CT增強掃描對局灶性肝病的定性診斷價值。
方法收集經本院完成螺旋CT增強掃描及菲立磁增強MRI掃描且臨床、手術病理證實為局灶性肝病者26例57個病灶，采用分組盲法受試者操作特性（ROC）曲線分析對比評價菲立磁增強MRI與螺旋CT增強掃描對局灶性肝病的定性診斷價值。
結果平掃+菲立磁增強MRI組ROC曲線下面積（Az值）最大，為0.926 0，準確性為86.8%，差異有顯著性意義（P＜0.05）。螺旋CT增強掃描、MRI平掃及單獨分析菲立磁增強MRI 3種方法之間差異無顯著性意義（P gt;0.05）。
結論菲立磁增強MRI對肝局灶性病變的定性診斷價值高于螺旋CT增強掃描。聯合分析平掃+菲立磁增強MRI較單獨分析菲立磁增強能明顯改善病灶的定性診斷能力。

引用本文： 楊漢豐,宋彬,周翔平,余建群,陳衛霞,陳憲,孫家瑜,陳茀茀,朱紅梅. 菲立磁增強MRI對局灶性肝病的定性診斷價值. 中國普外基礎與臨床雜志, 2004, 11(5): 454-457下轉465. doi: 復制

1.	Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxidesenhanced MR imaging versus unenhanced MR imaging and CT during arterial portography [Ｊ]. Radiology, 1996; 200(3)∶785.
2.	Soyer P. Will ferumoxidesenhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future [Ｊ]. Radiology, 1996; 200(3)∶600.
3.	Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide——enhanced versus gadoliniumenhanced MR imaging for differential diagnosis of focal liver lesions [Ｊ]. Radiology, 1996; 198(3)∶881.
4.	Ishida T, Murakami T, Kato N, et al. Superparamagnetic iron oxide enhanced magnetic resonance imaging of rat liver with hepatocellular carcinoma and benign hyperplastic nodule [Ｊ]. Invest Radiol, 1997; 32(5)∶282.
5.	Grandin C, Van Beers BE, Robert A, et al. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration [Ｊ]. J Comput Assist Tomogr, 1995; 19(3)∶412.
6.	Paley MR, Mergo PJ, Torres GM, et al. Characterization of focal hepatic lesions with ferumoxidesenhanced T2weighted MR imaging [Ｊ]. AJR Am J Roentgenol, 2000; 175(1)∶159.
7.	Nakayama M, Yamashita Y, Mitsuzaki K, et al. Improved tissue characterization of focal liver lesions with ferumoxideenhanced T1 and T2weighted MR imaging [Ｊ]. J Magn Reson Imaging, 2000; 11(6)∶647.
8.	Grangier C, Tourniaire J, Mentha G, et al. Enhancement of liver hemangiomas on T1weighted MR SE images by superparamagnetic iron oxide particles [Ｊ]. J Comput Assist Tomogr, 1994; 18(6)∶888.
9.	Sahani D, Saini S, Sharma R, et al. Dynamic T1weighted ferumoxides enhanced MRI for imaging liver hemangiomas: preliminary observations [Ｊ]. Abdom Imaging, 2001; 26(2)∶166.
10.	劉劍羽，謝敬霞，姚學會，等. 菲立磁增強MRI在肝臟局灶性病變的診斷價值 [Ｊ]. 臨床放射學雜志， 2001； 20（4）∶256.
11.	Oudkerk M, van den Heuvel AG, Wielopolski PA, et al. Hepatic lesions: detection with ferumoxideenhanced T1weighted MR imaging [Ｊ]. Radiology, 1997; 203(2)∶449.

1. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxidesenhanced MR imaging versus unenhanced MR imaging and CT during arterial portography [Ｊ]. Radiology, 1996; 200(3)∶785.
2. Soyer P. Will ferumoxidesenhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future [Ｊ]. Radiology, 1996; 200(3)∶600.
3. Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide——enhanced versus gadoliniumenhanced MR imaging for differential diagnosis of focal liver lesions [Ｊ]. Radiology, 1996; 198(3)∶881.
4. Ishida T, Murakami T, Kato N, et al. Superparamagnetic iron oxide enhanced magnetic resonance imaging of rat liver with hepatocellular carcinoma and benign hyperplastic nodule [Ｊ]. Invest Radiol, 1997; 32(5)∶282.
5. Grandin C, Van Beers BE, Robert A, et al. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration [Ｊ]. J Comput Assist Tomogr, 1995; 19(3)∶412.
6. Paley MR, Mergo PJ, Torres GM, et al. Characterization of focal hepatic lesions with ferumoxidesenhanced T2weighted MR imaging [Ｊ]. AJR Am J Roentgenol, 2000; 175(1)∶159.
7. Nakayama M, Yamashita Y, Mitsuzaki K, et al. Improved tissue characterization of focal liver lesions with ferumoxideenhanced T1 and T2weighted MR imaging [Ｊ]. J Magn Reson Imaging, 2000; 11(6)∶647.
8. Grangier C, Tourniaire J, Mentha G, et al. Enhancement of liver hemangiomas on T1weighted MR SE images by superparamagnetic iron oxide particles [Ｊ]. J Comput Assist Tomogr, 1994; 18(6)∶888.
9. Sahani D, Saini S, Sharma R, et al. Dynamic T1weighted ferumoxides enhanced MRI for imaging liver hemangiomas: preliminary observations [Ｊ]. Abdom Imaging, 2001; 26(2)∶166.
10. 劉劍羽，謝敬霞，姚學會，等. 菲立磁增強MRI在肝臟局灶性病變的診斷價值 [Ｊ]. 臨床放射學雜志， 2001； 20（4）∶256.
11. Oudkerk M, van den Heuvel AG, Wielopolski PA, et al. Hepatic lesions: detection with ferumoxideenhanced T1weighted MR imaging [Ｊ]. Radiology, 1997; 203(2)∶449.

《中國普外基礎與臨床雜志》

菲立磁增強MRI對局灶性肝病的定性診斷價值

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

菲立磁增強MRI對局灶性肝病的定性診斷價值

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料